Literature DB >> 16174920

Osmotic therapy: fact and fiction.

Michael N Diringer1, Allyson R Zazulia.   

Abstract

This review examines the available data on the use of osmotic agents in patients with head injury and ischemic stroke, summarizes the physiological effects of osmotic agents, and presents the leading hypotheses regarding the mechanism by which they reduce ICP. Finally, it addresses the validity of the following commonly held beliefs: mannitol accumulates in injured brain; mannitol shrinks only normal brain and can increase midline shift; osmolality can be used to monitor mannitol administration; mannitol should be not be administered if osmolality is >320 mOsm; and hypertonic saline is equally effective as mannitol.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16174920     DOI： 10.1385/NCC:1:2:219

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


  108 in total

Review 1.  The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure.

Authors: 
Journal:  J Neurotrauma       Date:  2000 Jun-Jul       Impact factor: 5.269

2.  Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke.

Authors:  Stefan Schwarz; Dimitrios Georgiadis; Alfred Aschoff; Stefan Schwab
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

3.  Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates.

Authors:  P Horn; E Münch; P Vajkoczy; P Herrmann; M Quintel; L Schilling; P Schmiedek; L Schürer
Journal:  Neurol Res       Date:  1999-12       Impact factor: 2.448

4.  Blood pressure and intracranial pressure-volume dynamics in severe head injury: relationship with cerebral blood flow.

Authors:  G J Bouma; J P Muizelaar; K Bandoh; A Marmarou
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

5.  The effects of mannitol on blood viscosity.

Authors:  A M Burke; D O Quest; S Chien; C Cerri
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

6.  Quantitative measurements of regional cerebral blood volume using MRI in rats: effects of arterial carbon dioxide tension and mannitol.

Authors:  W Lin; R P Paczynski; K Kuppusamy; C Y Hsu; E M Haacke
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

7.  Treatment of right hemispheric cerebral infarction by hemicraniectomy.

Authors:  J B Delashaw; W C Broaddus; N F Kassell; E C Haley; G A Pendleton; D G Vollmer; W W Maggio; M S Grady
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

8.  Hypertonic saline resuscitation of head injury: effects on cerebral water content.

Authors:  D H Wisner; L Schuster; C Quinn
Journal:  J Trauma       Date:  1990-01

9.  Early mortality following stroke: a prospective review.

Authors:  F L Silver; J W Norris; A J Lewis; V C Hachinski
Journal:  Stroke       Date:  1984 May-Jun       Impact factor: 7.914

10.  Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol.

Authors:  S Berger; L Schürer; R Härtl; K Messmer; A Baethmann
Journal:  Neurosurgery       Date:  1995-07       Impact factor: 4.654
View more
  36 in total

1.  Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension.

Authors:  Julie J Lewandowski-Belfer; Alden V Patel; Robert M Darracott; Daniel A Jackson; Jerah D Nordeen; W David Freeman
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

2.  Variation in osmotic response to sustained mannitol administration.

Authors:  Salah G Keyrouz; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

3.  Treatment of traumatic brain injury in pediatrics.

Authors:  Andranik Madikians; Christopher C Giza
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

4.  Efficacy of reductive ventricular osmotherapy in a swine model of traumatic brain injury.

Authors:  Rick M Odland; Sandya Venugopal; John Borgos; Valerie Coppes; Alexander M McKinney; Gaylan Rockswold; Jian Shi; Scott Panter
Journal:  Neurosurgery       Date:  2012-02       Impact factor: 4.654

5.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

6.  Global cerebral edema from hypercapnic respiratory acidosis and response to hyperosmolar therapy.

Authors:  David Roh; Alexander E Merkler; Fawaz Al-Mufti; Nicholas Morris; Sachin Agarwal; Jan Claassen; Soojin Park
Journal:  Neurology       Date:  2016-03-18       Impact factor: 9.910

Review 7.  Care of the stroke patient: routine management to lifesaving treatment options.

Authors:  George A Lopez; Arash Afshinnik; Owen Samuels
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 8.  Osmotherapy in neurocritical care.

Authors:  Anish Bhardwaj
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

9.  Decreased infarct volume and intracranial hemorrhage associated with intra-arterial nonionic iso-osmolar contrast material in an MCA occlusion/reperfusion model.

Authors:  H Morales; A Lu; Y Kurosawa; J F Clark; J Leach; K Weiss; T Tomsick
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-08       Impact factor: 3.825

10.  Neurocritical care of patients with central nervous system infections.

Authors:  Andreas H Kramer; Thomas P Bleck
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.